![]() |
Mikhail Alexeyev Ph.D., center, and research technologists Natalya Kozhukhar, Ph.D., and Rafik Fayzulin, Ph.D., study mitochondrial DNA in the lab. |
A scientist at the University of South Alabama has challenged a key conclusion of a 2023 study on the maternal inheritance of mitochondrial DNA.
Mikhail Alexeyev, Ph.D., a professor of physiology and cell biology at the Frederick P. Whiddon College of Medicine, provides a critical analysis of the study in Nature Genetics, a high-impact scientific journal. His article, “An alternative model for maternal mtDNA inheritance,” is published in the journal’s March 2025 issue.
Understanding how mitochondrial DNA (mtDNA) is inherited “will inform our approaches to genetic counseling for mitochondrial disease and male infertility, as well as the development of gene therapy strategies for treating mitochondrial disorders,” Alexeyev said.
In most species, mtDNA is inherited from a single parent. The current understanding is that, in humans, mtDNA is inherited exclusively from the mother. Scientists have identified several mechanisms in different species that ensure uniparental inheritance of mtDNA. However, it is still unclear how these mechanisms work in humans. Interestingly, studies have shown that mtDNA content in human sperm inversely correlates with fertility: As the amount of mtDNA in sperm increases, fertility tends to decrease.The study that Alexeyev challenges was conducted by researchers at Thomas Jefferson University in Philadelphia and published in the September 2023 issue of Nature Genetics. The authors demonstrated that human sperm contains little to no mtDNA, less than previously thought. They also confirmed earlier findings that sperm were missing two proteins – POLG and POLRMT – that are essential for maintaining mtDNA.
Another important finding in the Jefferson University study involved a protein called TFAM. Normally, TFAM is found in the mitochondria, the energy-producing parts of cells, where it plays a key role in maintaining and regulating mtDNA. However, in sperm, TFAM is primarily located in other areas of the cell, like the nucleus (the cell’s control center) and cytosol (the fluid in the cell that surrounds the organelles).
The researchers also found that TFAM is chemically modified through phosphorylation, a process in which a phosphate group is added to the protein. They suggest that this modification prevents TFAM from entering the mitochondria, which may account for the loss of mtDNA in sperm. In other words, this alteration in TFAM’s location and function could explain why sperm don’t pass on mitochondrial DNA.
In his critique of the Jefferson University study, Alexeyev invokes Occam’s razor, a principle that suggests the simplest explanation – the one that requires the fewest assumptions – is usually the best. He proposes a more straightforward model: “Sperm lacks mtDNA because it is missing POLG and POLRMT, as well as two other proteins, TFB2M and TWNK,” he explained. “In the absence of any of these four proteins, mtDNA is lost, and the combined loss of all four presents a compelling argument – one that our reviewers acknowledged.”
Alexeyev said the Jefferson University model is difficult to prove but can be easily falsified. “For example, the paper provides evidence that as many as three proteins (TFAM, POLG and POLRMT) and potentially as many as five (adding TFB2M and TWNK) essential for mtDNA maintenance might be missing from sperm mitochondria. If so,” he asks, “why would TFAM alone be responsible for mtDNA loss?”
In response to Alexeyev’s criticism, the authors put forward a hypothesis that TFAM, unlike the other four proteins, physically shields mtDNA from nucleases. Nucleases are enzymes that are designed to break apart the nucleotides that make up the nucleic acids DNA and RNA. Therefore, TFAM relocalization from mitochondria would have the additional consequence of making mtDNA vulnerable to attack by nucleases, which leads to accelerated mtDNA loss.
“In our rebuttal, we point out that this assumption is contradicted by experimental evidence,” Alexeyev said. “Indeed, mtDNA remains accessible to mitochondrially expressed nucleases. We and others have used this accessibility to develop methods for mtDNA elimination from cells.”
Recently, the Alexeyev lab used the GeneSwap method, as described in their paper “A method for in situ reverse genetic analysis of proteins involved in mtDNA replication,” to substitute normal TFAM in cells with mutant forms that mimic the phosphorylated version found in sperm. These modified cells retain mtDNA, contradicting the model proposed by the Jefferson University team.
Alexeyev's work, including his use of innovative gene-editing techniques, may help refine our understanding of mtDNA inheritance and its role in human health. If researchers can uncover the precise mechanisms behind mtDNA inheritance, it could open new avenues for gene therapy and treatment strategies.
Read the full article in Nature Genetics: “An alternative model for maternal mtDNA inheritance.”